"page","tableheading","tablestart.pos","tablelastline","tableend.pos","legendlastline","legendend.pos","txtfirstline","detected.in","searchwords.found"
3,"Table 1 Characteristics of all the enrolled data.",128,"MAP vs MAP-M",239,"trial.",241,"3","txtandhtml","YES"
6,"Table 2 Baseline characteristics of all enrolled p",46,"0",134,"MAP+ = MAP plus ifosfamide and etoposide, or other adjuvant therapy drugs, MAP = methotrexate, doxorubicin, and cisplatin.",136,"Patients receiving chemotherapy (MAP or MAP+) had a better","txtandhtml","YES"
